(BEI) Beiersdorf - Ratings and Ratios
SkinCare, AdhesiveTapes, BodyCare, SelfAdhesiveSolutions
BEI EPS (Earnings per Share)
BEI Revenue
Description: BEI Beiersdorf
Beiersdorf Aktiengesellschaft is a leading global consumer goods company operating in multiple regions, including Europe, the United States, Africa, Asia, and Australia. The company is divided into two main segments: Consumer Business, which focuses on skin and body care products, and Tesa Business, which provides adhesive tapes and self-adhesive solutions for various industries and consumers.
The companys diverse portfolio includes well-known brands such as NIVEA, Eucerin, and tesa, catering to different markets, including automotive, consumer electronics, and printing and packaging. With a history dating back to 1882, Beiersdorf has established itself as a prominent player in the personal care products industry, with a strong presence in Germany and a global footprint.
From a financial perspective, Beiersdorfs market capitalization stands at approximately €24.4 billion, indicating a significant market presence. The companys return on equity (RoE) is around 19.73%, suggesting a relatively strong profitability. The forward price-to-earnings (P/E) ratio is approximately 23.42, which may indicate a moderate valuation. Additionally, Beiersdorfs dividend yield and payout ratio could be analyzed to assess the companys ability to generate returns for shareholders.
To further evaluate Beiersdorfs performance, key performance indicators (KPIs) such as revenue growth, gross margin, and operating margin could be examined. For instance, analyzing the companys revenue growth over the past few years could provide insights into its ability to expand its market share and adapt to changing consumer trends. Furthermore, examining Beiersdorfs gross margin and operating margin could help assess its pricing power, cost management, and operational efficiency.
BEI Stock Overview
| Market Cap in USD | 26,250m |
| Sub-Industry | Personal Care Products |
| IPO / Inception |
BEI Stock Ratings
| Growth Rating | -12.7% |
| Fundamental | 84.0% |
| Dividend Rating | 51.5% |
| Return 12m vs S&P 500 | -35.5% |
| Analyst Rating | - |
BEI Dividends
| Dividend Yield 12m | 0.91% |
| Yield on Cost 5y | 1.07% |
| Annual Growth 5y | 7.39% |
| Payout Consistency | 92.8% |
| Payout Ratio | 18.4% |
BEI Growth Ratios
| Growth Correlation 3m | -69.1% |
| Growth Correlation 12m | -78% |
| Growth Correlation 5y | 79.6% |
| CAGR 5y | 1.03% |
| CAGR/Max DD 5y | 0.03 |
| Sharpe Ratio 12m | -1.06 |
| Alpha | -27.99 |
| Beta | -0.002 |
| Volatility | 17.94% |
| Current Volume | 254.7k |
| Average Volume 20d | 343.9k |
| Stop Loss | 95.2 (-3.1%) |
| Signal | -2.14 |
Piotroski VR‑10 (Strict, 0-10) 10.0
| Net Income (1.62b TTM) > 0 and > 6% of Revenue (6% = 1.17b TTM) |
| FCFTA 0.09 (>2.0%) and ΔFCFTA 6.92pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 14.75% (prev 16.96%; Δ -2.22pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.16 (>3.0%) and CFO 2.04b > Net Income 1.62b (YES >=105%, WARN >=100%) |
| Net Debt (-1.09b) to EBITDA (2.30b) ratio: -0.48 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.76 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (220.2m) change vs 12m ago -2.91% (target <= -2.0% for YES) |
| Gross Margin 58.36% (prev 56.70%; Δ 1.65pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 152.0% (prev 106.7%; Δ 45.28pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 39.63 (EBITDA TTM 2.30b / Interest Expense TTM 41.0m) >= 6 (WARN >= 3) |
Altman Z'' 6.61
| (A) 0.22 = (Total Current Assets 6.65b - Total Current Liabilities 3.77b) / Total Assets 12.92b |
| (B) 0.67 = Retained Earnings (Balance) 8.69b / Total Assets 12.92b |
| (C) 0.13 = EBIT TTM 1.62b / Avg Total Assets 12.86b |
| (D) 2.01 = Book Value of Equity 8.94b / Total Liabilities 4.46b |
| Total Rating: 6.61 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 83.96
| 1. Piotroski 10.0pt = 5.0 |
| 2. FCF Yield 5.60% = 2.80 |
| 3. FCF Margin 6.16% = 1.54 |
| 4. Debt/Equity 0.02 = 2.50 |
| 5. Debt/Ebitda 0.06 = 2.50 |
| 6. ROIC - WACC 7.44% = 9.30 |
| 7. RoE 19.23% = 1.60 |
| 8. Rev. Trend 66.65% = 3.33 |
| 9. Rev. CAGR 43.90% = 2.50 |
| 10. EPS Trend 15.87% = 0.40 |
| 11. EPS CAGR 48.19% = 2.50 |
What is the price of BEI shares?
Over the past week, the price has changed by -1.33%, over one month by -11.26%, over three months by -18.61% and over the past year by -24.54%.
Is Beiersdorf a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of BEI is around 80.61 EUR . This means that BEI is currently overvalued and has a potential downside of -17.95%.
Is BEI a buy, sell or hold?
What are the forecasts/targets for the BEI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 124.7 | 27% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 87.9 | -10.5% |
BEI Fundamental Data Overview
Market Cap EUR = 22.54b (22.54b EUR * 1.0 EUR.EUR)
CCE Cash And Equivalents = 1.17b EUR (last quarter)
P/E Trailing = 25.5779
P/E Forward = 23.31
P/S = 2.2849
P/B = 2.6431
P/EG = 2.9865
Beta = 0.302
Revenue TTM = 19.55b EUR
EBIT TTM = 1.62b EUR
EBITDA TTM = 2.30b EUR
Long Term Debt = 132.0m EUR (from longTermDebt, last quarter)
Short Term Debt = unknown (0.0)
Debt = 132.0m EUR (Calculated: Short Term 0.0 + Long Term 132.0m)
Net Debt = -1.09b EUR (from netDebt column, last fiscal year)
Enterprise Value = 21.50b EUR (22.54b + Debt 132.0m - CCE 1.17b)
Interest Coverage Ratio = 39.63 (Ebit TTM 1.62b / Interest Expense TTM 41.0m)
FCF Yield = 5.60% (FCF TTM 1.20b / Enterprise Value 21.50b)
FCF Margin = 6.16% (FCF TTM 1.20b / Revenue TTM 19.55b)
Net Margin = 8.29% (Net Income TTM 1.62b / Revenue TTM 19.55b)
Gross Margin = 58.36% ((Revenue TTM 19.55b - Cost of Revenue TTM 8.14b) / Revenue TTM)
Tobins Q-Ratio = 2.41 (Enterprise Value 21.50b / Book Value Of Equity 8.94b)
Interest Expense / Debt = 20.45% (Interest Expense 27.0m / Debt 132.0m)
Taxrate = 30.02% (from yearly Income Tax Expense: 398.0m / 1.33b)
NOPAT = 1.14b (EBIT 1.62b * (1 - 30.02%))
Current Ratio = 1.76 (Total Current Assets 6.65b / Total Current Liabilities 3.77b)
Debt / Equity = 0.02 (Debt 132.0m / last Quarter total Stockholder Equity 8.47b)
Debt / EBITDA = 0.06 (Net Debt -1.09b / EBITDA 2.30b)
Debt / FCF = 0.11 (Debt 132.0m / FCF TTM 1.20b)
Total Stockholder Equity = 8.42b (last 4 quarters mean)
RoA = 12.53% (Net Income 1.62b, Total Assets 12.92b )
RoE = 19.23% (Net Income TTM 1.62b / Total Stockholder Equity 8.42b)
RoCE = 18.99% (Ebit 1.62b / (Equity 8.42b + L.T.Debt 132.0m))
RoIC = 13.50% (NOPAT 1.14b / Invested Capital 8.43b)
WACC = 6.06% (E(22.54b)/V(22.67b) * Re(6.01%)) + (D(132.0m)/V(22.67b) * Rd(20.45%) * (1-Tc(0.30)))
Shares Correlation 5-Years: -89.40 | Cagr: -0.74%
Discount Rate = 6.01% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
[DCF Debug] Terminal Value 81.43% ; FCFE base≈845.1m ; Y1≈1.04b ; Y5≈1.78b
Fair Price DCF = 136.7 (DCF Value 30.25b / Shares Outstanding 221.4m; 5y FCF grow 25.0% → 3.0% )
Revenue Correlation: 66.65 | Revenue CAGR: 43.90%
Rev Growth-of-Growth: 16.06
EPS Correlation: 15.87 | EPS CAGR: 48.19%
EPS Growth-of-Growth: 73.71